By: IPP Bureau
Last updated : April 01, 2025 10:24 am
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system
HRV Global Life Sciences, India’s first virtual integrated pharmaceutical company, announces the successful delivery of the first shipment of anti-diabetic medications to Mendoza, Argentina.
The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system. This historic moment marks a significant step in strengthening relationship between India and Argentina, aiming to provide affordable healthcare solutions to thousands of Argentine patients.
“This landmark shipment represents more than just a business collaboration—it is a testament to our commitment to making affordable healthcare accessible to all. We are proud to support Argentina’s healthcare system and strengthen the bond between our two nations. As Rodolfo Montero, Mendoza’s Minister of Health, described, this delivery truly marks a historic achievement for both Argentina and India," said Hari Kiran Chereddi, Managing Director, HRV Global Life Sciences.
HRV Global Life Sciences is deepening its partnership with Argentina and providing life-saving medications to Latin America. The scope of this initiative is being extended to more provinces of Argentina and additional therapeutic segments including Oncology and Cardiology. These medications were manufactured in HRV’s CDMO partner site and serves as the validation of HRV’s virtual pharma model for the first time in India for both API and FDF. This initiative represents the first of many, reaffirming HRV Global Life Sciences’ vision for a healthier, more accessible future.